Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents
Gastrointestinal adverse events occurred in 79.6% of CagriSema participants versus 39.9% with placebo, were mostly transient, and led to discontinuation in 6-8.4% of participants
Trimetazidine protects against myocardial ischemia/reperfusion injury by inhibiting excessive autophagy
Die Patches werden einfach auf die Haut geklebt, mglichst direkt auf die Stelle, wo das Peptid wirken soll
Its broad activity across multiple tissue types an unusual characteristic for a single peptide compound has been a recurring focus of mechanistic discussion in the research literature, with studies examining growth hormone receptor upregulation as a potential unifying mechanism